期刊
STEROIDS
卷 133, 期 -, 页码 75-81出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2017.12.015
关键词
Progesterone receptor; Breast cancer; Repressive actions
资金
- National Institute of Cancer
- National Agency of Scientific Promotion of Argentina (ANPCyT) [2015-1587, PID 2012-066, IDB/PICT 2012-668]
- Grant Fondation Nelia et Amadeo Barletta-Switzerland
- ANPCyT [IDB/PICT 2008-189, 2012-1017]
- CONICET [PIP 59]
Progesterone receptor (PR) is a master regulator in female reproductive tissues that controls developmental processes and proliferation and differentiation during the reproductive cycle and pregnancy. PR also plays a role in progression of endocrine-dependent breast cancer. As a member of the nuclear receptor family of ligand-dependent transcription factors, the main action of PR is to regulate networks of target gene expression in response to binding its cognate steroid hormone, progesterone. Liganded-PR transcriptional activation has been thoroughly studied and associated mechanisms have been described while progesterone-mediated repression has remained less explored. The present work summarizes recent advances in the understanding of how PR-mediated repression is accomplished in breast cancer cells and highlights the significance of fully understanding the determinants of context-dependent PR action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据